StockData
Genenta Science S.p.A. logo

Genenta Science S.p.A. (SAEN) stock

SAENNasdaqBiological Products, (No Diagnostic Substances)
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.58+0.00 (+0.85%)

Close on Nov 18, 2026Market cap $13.64MP/E –Yield –

Genenta Science S.p.A. net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was -€6.53M. The highest annual figure on record is -€4.60M in fiscal 2019.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-€6.53M–
FY2024Dec 31, 2024-€8.91M–
FY2023Dec 31, 2023-€11.65M–
FY2022Dec 31, 2022-€8.48M–
FY2021Dec 31, 2021-€5.53M–
FY2020Dec 31, 2020-€5.59M–
FY2019Dec 31, 2019-€4.60M–

More Genenta Science S.p.A. figures

See a number that looks wrong?